Ardelyx

$6.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.02 (-0.29%) Today
$0.00 (0.00%) As of 4:42 PM EST after-hours

Why Robinhood?

You can buy or sell Ardelyx and other stocks, options, ETFs, and crypto commission-free!

About ARDX

Ardelyx, Inc. Common Stock, also called Ardelyx, is a biopharmaceutical company, which engages in the research, development and commercialization of medicine for the treatment of renal diseases. Read More It focuses on the formulation of programs directed toward treating gastrointestinal and irritable bowel syndrome with constipations. Its product portfolio includes tenapanor, which is an experimental medication that works exclusively in the gut and is in late-stage clinical development. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet on October 17, 2007 and is headquartered in Fremont, CA.

Employees
86
Headquarters
Fremont, California
Founded
2007
Market Cap
506.41M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
1.54M
High Today
$7.15
Low Today
$6.25
Open Price
$6.90
Volume
4.94M
52 Week High
$8.31
52 Week Low
$1.60

Collections

ARDX News

ReutersDec 3

Ardelyx drug reduces elevated phosphate levels, late-stage study shows

(Reuters) - Ardelyx Inc’s experimental drug has shown promise in a late-stage study as a standalone therapy to reduce elevated blood phosphate levels in patient
214

ARDX Earnings

-$0.46
-$0.43
-$0.39
-$0.36
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
—
Actual
Expected Mar 4, After Hours

You May Also Like

Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.